[go: up one dir, main page]

PL380409A1 - Proces syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli - Google Patents

Proces syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli

Info

Publication number
PL380409A1
PL380409A1 PL380409A PL38040904A PL380409A1 PL 380409 A1 PL380409 A1 PL 380409A1 PL 380409 A PL380409 A PL 380409A PL 38040904 A PL38040904 A PL 38040904A PL 380409 A1 PL380409 A1 PL 380409A1
Authority
PL
Poland
Prior art keywords
formula
give
reacting
compound
perindopril
Prior art date
Application number
PL380409A
Other languages
English (en)
Other versions
PL210769B1 (pl
Inventor
Thierry Dubuffet
Pascal Langlois
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL380409A1 publication Critical patent/PL380409A1/pl
Publication of PL210769B1 publication Critical patent/PL210769B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL380409A 2003-11-19 2004-11-18 Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli oraz związek przejściowy PL210769B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03292864A EP1420028B1 (fr) 2003-11-19 2003-11-19 Pocédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
PCT/FR2004/002936 WO2005054276A1 (fr) 2003-11-19 2004-11-18 Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
PL380409A1 true PL380409A1 (pl) 2007-01-22
PL210769B1 PL210769B1 (pl) 2012-02-29

Family

ID=32116380

Family Applications (1)

Application Number Title Priority Date Filing Date
PL380409A PL210769B1 (pl) 2003-11-19 2004-11-18 Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli oraz związek przejściowy

Country Status (28)

Country Link
US (1) US7208607B1 (pl)
EP (1) EP1420028B1 (pl)
JP (1) JP4377412B2 (pl)
KR (1) KR100863394B1 (pl)
CN (1) CN100447152C (pl)
AR (1) AR047312A1 (pl)
AT (1) ATE354586T1 (pl)
AU (1) AU2004295132B2 (pl)
BR (1) BRPI0416746B1 (pl)
CA (1) CA2546506C (pl)
CY (1) CY1106544T1 (pl)
DE (1) DE60311942T2 (pl)
DK (1) DK1420028T3 (pl)
EA (1) EA010102B1 (pl)
EG (1) EG26629A (pl)
ES (1) ES2282586T3 (pl)
GE (1) GEP20084547B (pl)
MA (1) MA28144A1 (pl)
MX (1) MXPA06005607A (pl)
MY (1) MY138550A (pl)
NO (1) NO336349B1 (pl)
NZ (1) NZ546931A (pl)
PL (1) PL210769B1 (pl)
PT (1) PT1420028E (pl)
SI (1) SI1420028T1 (pl)
UA (1) UA83269C2 (pl)
WO (1) WO2005054276A1 (pl)
ZA (1) ZA200603675B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380591B1 (fr) * 2003-08-29 2005-11-16 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
WO2007006003A2 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
ES2566479T3 (es) 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
EP2816024B8 (en) 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Chiral amines
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CN101686672A (zh) 2007-05-31 2010-03-31 塞普拉柯公司 苯基取代的环烷胺作为一元胺再摄取抑制剂
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN112047869B (zh) * 2020-08-20 2021-12-21 华南理工大学 一种氮杂5,6-并环化合物的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese

Also Published As

Publication number Publication date
EP1420028A2 (fr) 2004-05-19
AU2004295132B2 (en) 2010-07-15
DE60311942T2 (de) 2007-12-06
DK1420028T3 (da) 2007-06-18
JP2008502587A (ja) 2008-01-31
NO20062599L (no) 2006-06-06
NO336349B1 (no) 2015-08-03
CY1106544T1 (el) 2012-01-25
JP4377412B2 (ja) 2009-12-02
MXPA06005607A (es) 2006-08-17
US20070083052A1 (en) 2007-04-12
ES2282586T3 (es) 2007-10-16
BRPI0416746B1 (pt) 2018-02-14
EP1420028A3 (fr) 2004-05-26
ATE354586T1 (de) 2007-03-15
PL210769B1 (pl) 2012-02-29
ZA200603675B (en) 2007-09-26
DE60311942D1 (de) 2007-04-05
CN100447152C (zh) 2008-12-31
EP1420028B1 (fr) 2007-02-21
UA83269C2 (uk) 2008-06-25
KR100863394B1 (ko) 2008-10-14
KR20060121202A (ko) 2006-11-28
AU2004295132A1 (en) 2005-06-16
EA200600898A1 (ru) 2006-10-27
EA010102B1 (ru) 2008-06-30
EG26629A (en) 2014-04-13
US7208607B1 (en) 2007-04-24
AR047312A1 (es) 2006-01-18
NZ546931A (en) 2010-01-29
WO2005054276A1 (fr) 2005-06-16
BRPI0416746A (pt) 2007-01-16
GEP20084547B (en) 2008-11-25
MA28144A1 (fr) 2006-09-01
CA2546506A1 (fr) 2005-06-16
CN1882607A (zh) 2006-12-20
MY138550A (en) 2009-06-30
CA2546506C (fr) 2010-04-06
PT1420028E (pt) 2007-05-31
HK1096689A1 (en) 2007-06-08
SI1420028T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
PL380409A1 (pl) Proces syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
CA2073510A1 (en) Peptidyl derivatives
MA27130A1 (fr) Nouveau procede de synthese de derives de l'acide (2s,3as,7as)-1-[(s)-alanyl]-octahydro- 1h-indole-2-carboxylique et application a la synthese du perindopril
AP1741A (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis
CZ285593B6 (cs) Způsob výroby (S)-3-amino-1-substituovaných pyrrolidinů
MA27633A1 (fr) Nouveau procede de synthese de l'acide (2s)-indoline -2-carboxylique, et application a la synthese du perindopril.
JP3872344B2 (ja) N−〔(s)−1−カルボキシブチル〕−(s)−アラニンエステルの新規合成方法及びペリンドプリルの合成における適用
US7223872B2 (en) Process for the synthesis of perindopril and its pharmaceutically acceptable salts
UA73562C2 (uk) Спосіб синтезу n-[(s)-1-карбоксибутил]-(s)-аланінових ефірів і їх застосування у синтезі периндоприлу
WO2009098251A1 (en) NOVEL CYCLOALKANONE β-SUBSTITUTED ALANINE DERIVATIVES
US20070043103A1 (en) Novel metod for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
CN1331883C (zh) (2S,3aS,7aS)-1-[(S)-丙氨酰]-八氢-1H-吲哚-2-甲酸衍生物的新合成方法及其在合成培哚普利中的应用
JP4331206B2 (ja) ペリンドプリルおよびその薬学的に許容され得る塩の、新規な合成方法
WO2004078707A3 (fr) Nouveau procede de synthese de lacide (2s, 3as, 7as)-perhydroindole-2-carboxylique et de ses esters et application a la synthese du perindopril
NZ187538A (en) 2-amino-2-halomethyl-3-phenylpropionic acid derivatives
JP2006506337A (ja) アミノ−ピロリジン誘導体を製造するための方法
WO2004082357A3 (fr) NOUVEAU PROCEDE DE SYNTHESE DE DERIVES DE L'ACIDE (2S, 3aS, 7aS)­-1-[(S)-ALANYL]-OCTAHYDRO-lH-INDOLE-2- CARBOXYLIQUE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL
WO2004099138A3 (en) Process for the preparation of perindopril
JP4263743B2 (ja) ペリンドプリル及びその薬学的に許容し得る塩の新規な合成方法
US7368580B2 (en) Method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
Ross et al. Synthesis of 2S-[2-2H]-kynurenine and use in kinetic isotope effect studies with kynureninase
MY136549A (en) NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND ESTERS THEREOF, AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL
JP4608922B2 (ja) 含窒素複素環化合物の製造方法
MA28223A1 (fr) NOUVEAU PROCEDE DE SYNTHESE DE DERIVES DE L'ACIDE (2S,3aS,7aS)-1-[(S)-ALANYL]-OCTAHYDRO-1H-INDOLE-2-CARBOXYLIQUE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL
JPS5920256A (ja) 2−(2,6−ジフルオロアニリノ)フエニル酢酸誘導体